Global Guillain-Bare Syndrome Market Size, Share, and COVID-19 Impact Analysis, By Type (Acute Motor Axonal Neuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Acute Inflammatory Demyelinating Polyneuropathy, and Miller Fisher Syndrome), By Treatment (Plasma Exchange, Intravenous Immunoglobulin (IVIG), and Others), By Route of Administration (Parenteral and Oral), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
Premium Report Details
Base Year:
2023
Tables & Figures:
110
Pages:
288
Countries covered:
17
Companies covered::
20
Forecast CAGR:
5.99%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies